Stifel Lowers Zoetis (ZTS) PT to $130, Maintains 'Hold' Due to Aggressive 2026 Revenue Outlook
Zoetis Inc. (NYSE:ZTS) is one of the most profitable large cap stocks to buy right now.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Unisphere Establishment Hani Lazkani (Ceo) | 4,800,000 | $702,336,000 | 5.51% | |
| 2. | Fundsmith LLP Terry Smith | 3,615,131 | $528,965,968 | +26% | 2.67% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,697,827 | $394,746,047 | +84% | 0.25% |
| 4. | Diamond Hill Capital Ric Dillon | 2,692,799 | $394,010,350 | 1.87% | |
| 5. | Impax Asset Management Ian Simm | 1,693,701 | $247,822,379 | +44% | 1.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | $347,508.00 | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | $478,181.00 | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | $424,242.00 | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | $745.60 | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | $352.17 | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $170.00 | 652 | $110,840.00 | 15,129 | 2025-06-03 | Filing | |
| $170.00 | 326 | $55,420.00 | 15,781 | 2025-03-10 | Filing | |
| $166.14 | 1,210 | $201,029.40 | 11,245 | 2025-03-11 | Filing | |
| $156.68 | 382 | $59,852.26 | 94,194 | 2025-02-19 | Filing | |
| $171.18 | 326 | $55,804.68 | 16,107 | 2025-02-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 42,306,764 | $6,190,325,709 | 0.09% | |
| 2. | 36,198,603 | $5,296,579,629 | 0.09% | |
| 3. | 19,647,509 | $2,874,823,517 | 0.1% | |
| 4. | 16,943,177 | $2,479,126,228 | 0.15% | |
| 5. | 15,892,903 | $2,325,449,567 | 1.94% |
News See All
12 Most Profitable Large Cap Stocks to Buy Right Now
On November 21, John Stoltzfus, Oppenheimer chief investment strategist, joined CNBC's 'The Exchange' to talk about where to look for market opportunities and discuss investment opportunities amidst current...
Zoetis (ZTS) Hits New 52-Week Low on Dismal Outlook
In intra-day trading, Zoetis Inc.
Zoetis Inc. (NYSE:ZTS) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Third Quarter 2025 Financial Results Conference Call and Webcast for Zoetis.
Should You Consider Adding Zoetis (ZTS) to Your Portfolio?
Diamond Hill Capital, an investment management company, released its “Select Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Zoetis Inc. (ZTS): A Bull Case Theory
We came across a bullish thesis on Zoetis Inc. on Summit Stocks’s Substack. In this article, we will summarize the bulls’ thesis on ZTS.
Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks
Zoetis Inc. (NYSE:ZTS) offers a range of drugs and healthcare products for companion animals and livestock worldwide.
13 Most Profitable Dividend Stocks to Buy Right Now
In a period marked by market volatility, ongoing policy and geopolitical uncertainty, many investors have been shifting toward fixed-income assets and away...
Zoetis Inc. (ZTS) Could Launch First Long-Acting Anti-NGF Therapy for Cats in Q4 2025
Zoetis Inc. (NYSE:ZTS), a global leader in animal health, reported solid second-quarter 2025 results with revenue rising 4% year-over-year to $2.5 billion and net income up 15% to $718 million.
12 Best Healthcare Stocks to Buy and Hold for 5 Years
Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after contacting carriers via phone and email. This can be changed by Dr.
Hedge Fund Resource Center Billionaire Hedge Funds
